Skip to content

Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in China

Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04961125
Enrollment
200
Registered
2021-07-14
Start date
2021-08-02
Completion date
2024-12-31
Last updated
2021-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Polyposis

Brief summary

Patients suspected of adenomatous polyposis were included. The criteria used were more than 10 polyps observed under colonoscopy, and pathological confirmation of adenoma. Clinical data and pedigree information were collected. The variants of 139 genes associated with different hereditary cancers and polyposis were screened by NGS, which was performed by Genetron Health on the HiSeqX-ten sequencing platform.

Interventions

GENETICgermline variants

Variants of 139 genes associated with different hereditary cancers and polyposis were screened by next-generation sequencing.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. clinical diagnosis of adenomatous polyposis; 2. enough samples (provide at least 5ml of peripheral whole blood) for germline variant detection

Exclusion criteria

genetic diagnosis of polyposis syndrome

Design outcomes

Primary

MeasureTime frameDescription
germline variant detection rate in the polyposis populationthrough study completion, an average of 3 yearsgermline variant detection rate in the polyposis population

Countries

China

Contacts

Primary ContactYing Yuan, PhD
yuanying1999@zju.edu.cn86-13858193601
Backup ContactDong Xu, PhD
xudongzju@zju.edu.cn86-13858191696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026